Search:

Our Database

Welcome to BIOJERUSALEM

BIOJERUSALEM is a one-stop connection for those who have made the science of life their business. It is at the vital heart of Jerusalem's thriving life sciences industry and serves as the primary resource for anyone involved in this exciting field.

BIOJERUSALEM is your portal to life sciences in a city like no other. Use our services to explore innovative opportunities to expand and grow your business ventures. We invite you to join the numerous biotechnology, pharmaceutical and medical device companies already realizing the enormous potential of Jerusalem.

Learn more how BIOJERUSALEM's resources can help you.

Click here to learn about our financial incentive package for biomed companies

Click to view BIOJERUSALEM's video presentation

Latest News

Jul. 22, 2009
BioLineRx Initiates Phase I/II Trial Of BL-5010, A Novel Formulation For The Non Surgical Removal Of Skin Lesions
read more..

Jun. 29, 2009
Israel sets up 1 billion shekel biotech fund
read more..

Jun. 24, 2009
Atox Bio and Fast-Track Drugs & Biologics Sign an R&D Collaboration Agreement for the Development of Therapeutics for Sepsis and Septic Shock
read more..

Jun. 15, 2009
Yissum Signs a Collaboration Agreement with Aurum Ventures MKI for the Development of Breakthrough Liver-Bypassing Oral Drug Delivery Nanotechnology
read more..

Jun. 15, 2009
Jerusalem mayor plans NIS 100m investment in biomed
read more..

Jun. 15, 2009
UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
read more..

Jun. 15, 2009
Barkat to raise NIS 100 million for capital's biomed industry
read more..

Jun. 9, 2009
Yissum Introduces Novel Compound for the Treatment of Osteoporosis
read more..

Jun. 8, 2009
Occupancy begins at Jerusalem Bio Park
read more..

Jun. 8, 2009
Six HU scientists honored for benefiting humanity
read more..

Jun. 3, 2009
Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma
read more..

May. 27, 2009
First treatment begins in BioCancell ovarian cancer study
read more..

May. 25, 2009
Z-Cube, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd. Sign a Licensing Agreement for the Development of an Innovative Nanotechnology Drug Delivery System for the Treatment of Pain
read more..

May. 19, 2009
President of Israel Shimon Peres Tours Gamida Cell in Jerusalem
read more..

May. 10, 2009
Searching for a vaccine for rheumatoid arthritis
read more..

May. 4, 2009
Biocancell announces cancer treatment success
read more..

May. 4, 2009
NASA technology to transform ER diagnosis
read more..

Apr. 26, 2009
BiolineRX completes schizophrenia recruitment early
read more..

Apr. 23, 2009
Brainsway nears cocaine addiction study
read more..

Apr. 21, 2009
Hadasit licenses medical technology to Immuron
read more..

Apr. 20, 2009
HBL Portfolio Company Tolarex to Commence Phase I/IIa Trial of a Treatment for GVHD
read more..

Apr. 7, 2009
Israeli research gets to the heart of the matter
read more..

Apr. 6, 2009
Yissum Appoints Yaacov Michlin as Chief Executive Officer
read more..

Apr. 1, 2009
BioCancell Receives MoH Approval for Ovarian Cancer Trial; Starts Screening
read more..

Mar. 31, 2009
Bioresorbable gel, injected into infarcts, holds promise post-MI for preventing remodeling and improving survival
read more..

Mar. 30, 2009
Germany's Merck, Yissum set up nanotech start-up
read more..

Mar. 30, 2009
Hadassah Saves Life of a One Day Old Baby with Heart Block
read more..

Mar. 28, 2009
Innovation Award sees finalists from diverse sectors
read more..

Mar. 25, 2009
Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA)
read more..

Mar. 25, 2009
Yissum revenues rise 18%
read more..

Events

Jun. 15-17, 2009

ILSI-Biomed Israel 2009. Come and visit us at booth 21

Job Board

Click here to view new available positions in Jerusalem's life sciences industry.


© BIOJERUSALEM. All Rights Reserved.	Created by Volle'